002900 哈三联
已收盘 12-05 15:00:00
资讯
新帖
简况
哈三联:帕拉米韦注射液处于正常审评流程中
证券之星 · 12-02
哈三联:帕拉米韦注射液处于正常审评流程中
哈三联:截至2025年11月28日股东人数为39,668名
证券之星 · 12-01
哈三联:截至2025年11月28日股东人数为39,668名
哈三联:公司未与“veirfoo”品牌有过合作
证券之星 · 11-28
哈三联:公司未与“veirfoo”品牌有过合作
哈三联(002900)披露调整组织机构公告,11月25日股价上涨1.68%
证券之星 · 11-25
哈三联(002900)披露调整组织机构公告,11月25日股价上涨1.68%
哈三联最新公告:选举秦剑飞为董事长
证券之星 · 11-25
哈三联最新公告:选举秦剑飞为董事长
哈三联(002900)11月20日股东户数3.84万户,较上期减少2.92%
证券之星 · 11-24
哈三联(002900)11月20日股东户数3.84万户,较上期减少2.92%
异动快报:哈三联(002900)11月24日9点35分触及涨停板
证券之星 · 11-24
异动快报:哈三联(002900)11月24日9点35分触及涨停板
红日药业:哈三联是公司的委托生产企业
证券之星 · 11-13
红日药业:哈三联是公司的委托生产企业
股市必读:哈三联(002900)股东户数3.96万户,较上期减少2.98%
证券之星 · 11-13
股市必读:哈三联(002900)股东户数3.96万户,较上期减少2.98%
哈三联:帕拉米韦注射液适应症为治疗甲型或乙型流行性感冒
证券之星 · 11-12
哈三联:帕拉米韦注射液适应症为治疗甲型或乙型流行性感冒
哈三联:截至2025年11月10日股东人数为39,589名
证券之星 · 11-12
哈三联:截至2025年11月10日股东人数为39,589名
哈三联(002900)披露为全资子公司提供担保的进展公告,11月11日股价上涨0.83%
证券之星 · 11-11
哈三联(002900)披露为全资子公司提供担保的进展公告,11月11日股价上涨0.83%
哈三联:截至2025年10月31日股东人数为40,805名
证券之星 · 11-04
哈三联:截至2025年10月31日股东人数为40,805名
哈三联最新公告:以2643万元竞得威凯洱生物破产资产
证券之星 · 10-30
哈三联最新公告:以2643万元竞得威凯洱生物破产资产
哈三联第三季度净利亏损过亿元 同比降超900%
滚动播报 · 10-28
哈三联第三季度净利亏损过亿元 同比降超900%
哈三联(002900)2025年三季报简析:净利润同比下降614.61%,三费占比上升明显
证券之星 · 10-26
哈三联(002900)2025年三季报简析:净利润同比下降614.61%,三费占比上升明显
哈三联(002900)10月20日股东户数3.83万户,较上期增加1.96%
证券之星 · 10-25
哈三联(002900)10月20日股东户数3.83万户,较上期增加1.96%
哈三联最新公告:前三季度亏损2.09亿元
证券之星 · 10-24
哈三联最新公告:前三季度亏损2.09亿元
10月22日哈三联(002900)涨停分析:化妆品业务增长、新业务拓展驱动
证券之星 · 10-22
10月22日哈三联(002900)涨停分析:化妆品业务增长、新业务拓展驱动
异动快报:哈三联(002900)10月22日9点39分触及涨停板
证券之星 · 10-22
异动快报:哈三联(002900)10月22日9点39分触及涨停板
加载更多
公司概况
公司名称:
哈尔滨三联药业股份有限公司
所属行业:
医药制造业
上市日期:
2017-09-22
主营业务:
哈尔滨三联药业股份有限公司的主营业务是化学药品制剂及特色原料药的研发、生产和销售。公司的主要产品是神经系统药物、心血管系统、肌肉-骨骼系统药物、全身用抗感染药、血液和造血器官药、抗肿瘤药及免疫调节剂、消化道和代谢方面的药物、抗生素系列、驱虫药系列、解热镇痛类药物及营养补充剂、大健康板块。公司先后被认定为高新技术企业、国家企业技术中心、国家博士后科研工作站,连续六年入选“中国化药企业TOP100榜单”,公司综合能力与研发实力不断增强。
发行价格:
18.07
{"stockData":{"symbol":"002900","market":"SZ","secType":"STK","nameCN":"哈三联","latestPrice":13.95,"timestamp":1764918192000,"preClose":14.5,"halted":0,"volume":13141400,"delay":0,"changeRate":-0.0379,"floatShares":175000000,"shares":316000000,"eps":-0.603,"marketStatus":"已收盘","change":-0.55,"latestTime":"12-05 15:00:00","open":14.38,"high":14.38,"low":13.81,"amount":184000000,"amplitude":0.0393,"askPrice":13.96,"askSize":394,"bidPrice":13.95,"bidSize":62,"shortable":0,"etf":0,"ttmEps":-0.603,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.5,"symbolType":"stock","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":15.95,"lowLimit":13.05,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":316357550,"isCdr":false,"pbRate":2.41,"roa":"--","roe":"--","epsLYR":0.19,"committee":-0.548028,"marketValue":4413000000,"turnoverRate":0.0751,"status":1,"floatMarketCap":2441000000},"requestUrl":"/m/hq/s/002900","defaultTab":"news","newsList":[{"id":"2588003815","title":"哈三联:帕拉米韦注射液处于正常审评流程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2588003815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588003815?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:00","pubTimestamp":1764662454,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联(002900)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问 随着日本流感疫情的爆发公司研发的帕拉米韦注射液如果获得快速审批公司有储备的药材快速面对市场吗哈三联回复:尊敬的投资者您好,公司帕拉米韦注射液目前处于正常审评流程中,公司将积极跟踪后续审评进展,并结合市场供需建立关键物料储备。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200018437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2588744989","title":"哈三联:截至2025年11月28日股东人数为39,668名","url":"https://stock-news.laohu8.com/highlight/detail?id=2588744989","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588744989?lang=zh_cn&edition=full","pubTime":"2025-12-01 15:21","pubTimestamp":1764573681,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联(002900)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至11月30日公司的股东人数是多少?谢谢哈三联回复:尊敬的投资者您好,根据中国证券登记结算公司最新数据显示,截至2025年11月28日,公司股东人数为39,668名,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100012462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2586202069","title":"哈三联:公司未与“veirfoo”品牌有过合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2586202069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586202069?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:48","pubTimestamp":1764319691,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联(002900)11月28日在投资者关系平台上答复投资者关心的问题。投资者提问:请问你公司生产的veirfoo品牌双11期间(10.20-11.11)销量达5-7.5万件,销售额2500-5000万元,在抖音美妆品牌榜排名第1是真的吗 近期是否还有新品发布哈三联回复:尊敬的投资者您好,感谢您对公司的关注。公司未与“veirfoo”品牌有过合作。在美妆新品方面,公司研发工作正在有序进行中,敬请期待。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800022833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2586791604","title":"哈三联(002900)披露调整组织机构公告,11月25日股价上涨1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586791604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586791604?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:13","pubTimestamp":1764079989,"startTime":"0","endTime":"0","summary":"截至2025年11月25日收盘,哈三联报收于14.54元,较前一交易日上涨1.68%,最新总市值为46亿元。该股当日开盘14.16元,最高14.79元,最低13.8元,成交额达4.07亿元,换手率为16.33%。近日,哈尔滨三联药业股份有限公司发布公告称,公司于2025年11月25日召开第五届董事会第一次会议,审议通过《关于调整组织机构的议案》。本次调整为内部管理机构调整,不影响公司生产经营活动。调整后的组织机构图详见公告附件。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500038865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2586425729","title":"哈三联最新公告:选举秦剑飞为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586425729","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586425729?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:33","pubTimestamp":1764063203,"startTime":"0","endTime":"0","summary":"哈三联(002900.SZ)公告称,经公司第五届董事会第一次会议审议通过,选举秦剑飞为公司第五届董事会董事长,诸葛国民为公司第五届董事会副董事长,任期与公司第五届董事会任期一致。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500026136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2585685594","title":"哈三联(002900)11月20日股东户数3.84万户,较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585685594","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585685594?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:48","pubTimestamp":1763977709,"startTime":"0","endTime":"0","summary":"证券之星消息,近日哈三联披露,截至2025年11月20日公司股东户数为3.84万户,较11月10日减少1156.0户,减幅为2.92%。在化学制药行业个股中,哈三联股东户数高于行业平均水平,截至11月20日,化学制药行业平均股东户数为3.44万户。从股价来看,2025年11月10日至2025年11月20日,哈三联区间跌幅为4.45%,在此期间股东户数减少1156.0户,减幅为2.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2585316744","title":"异动快报:哈三联(002900)11月24日9点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2585316744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585316744?lang=zh_cn&edition=full","pubTime":"2025-11-24 09:41","pubTimestamp":1763948508,"startTime":"0","endTime":"0","summary":"证券之星11月24日盘中消息,9点35分哈三联触及涨停板。目前价格13.54,上涨4.15%。其所属行业化学制药目前上涨。领涨股为金石亚药。该股为化学原料药,创新药,医药概念热股,当日化学原料药概念上涨1.3%,创新药概念上涨1.23%,医药概念上涨1.22%。11月21日的资金流向数据方面,主力资金净流出1930.03万元,占总成交额13.17%,游资资金净流出756.73万元,占总成交额5.16%,散户资金净流入2686.76万元,占总成交额18.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400002574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2583801580","title":"红日药业:哈三联是公司的委托生产企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2583801580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583801580?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:45","pubTimestamp":1762994718,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业(300026)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司跟哈尔滨三联药业属于什么关系?,两家公司有众多合作申报品种红日药业回复:您好,哈三联是公司的委托生产企业。谢谢关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","002900","BK0077","300026"],"gpt_icon":0},{"id":"2583302036","title":"股市必读:哈三联(002900)股东户数3.96万户,较上期减少2.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583302036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583302036?lang=zh_cn&edition=full","pubTime":"2025-11-13 03:49","pubTimestamp":1762976952,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,哈三联报收于14.7元,上涨1.38%,换手率11.37%,成交量19.9万手,成交额2.94亿元。来自:截至11月10日股东户数环比下降2.98%,户均持股上升至7991.0股,筹码集中度有所提高。来自:公司为全资子公司提供2900万元连带责任保证担保,累计担保余额达16,300万元,占最近一期净资产的8.56%。股本股东变化股东户数变动截至2025年11月10日,公司股东户数为3.96万户,较10月31日减少1216.0户,减幅为2.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300004661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2582068348","title":"哈三联:帕拉米韦注射液适应症为治疗甲型或乙型流行性感冒","url":"https://stock-news.laohu8.com/highlight/detail?id=2582068348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582068348?lang=zh_cn&edition=full","pubTime":"2025-11-12 11:37","pubTimestamp":1762918623,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联11月11日在投资者关系平台上答复投资者关心的问题。H3N2属于甲型流感的一种亚型,是目前人类主要的季节性流感的流行毒株。公司将持续推进在研产品进展,感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200014633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2582348779","title":"哈三联:截至2025年11月10日股东人数为39,589名","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348779","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582348779?lang=zh_cn&edition=full","pubTime":"2025-11-12 11:36","pubTimestamp":1762918588,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联(002900)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘好,请问截至2025年11月10日,公司的股东人数是多少?谢谢。哈三联回复:尊敬的投资者您好,根据中国证券登记结算公司最新数据显示,截至2025年11月10日,公司股东人数为39,589名,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200014565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2582367960","title":"哈三联(002900)披露为全资子公司提供担保的进展公告,11月11日股价上涨0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582367960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582367960?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:32","pubTimestamp":1762871548,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘,哈三联报收于14.5元,较前一交易日上涨0.83%,最新总市值为45.87亿元。公司近日发布公告,哈尔滨三联药业股份有限公司与招商银行股份有限公司哈尔滨分行签订《最高额不可撤销担保书》,为全资子公司兰西哈三联制药有限公司提供连带责任保证担保。本次担保主债权本金最高额为2900万元,担保范围包括贷款本金、利息、罚息、实现债权的费用等,保证期间为3年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100041015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2580273309","title":"哈三联:截至2025年10月31日股东人数为40,805名","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273309","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580273309?lang=zh_cn&edition=full","pubTime":"2025-11-04 08:54","pubTimestamp":1762217652,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联(002900)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请问截止2025年10月31日,公司股东数是多少?哈三联回复:尊敬的投资者您好,根据中国证券登记结算公司最新数据显示,截至2025年10月31日,公司股东人数为40,805名,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400006480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2579197483","title":"哈三联最新公告:以2643万元竞得威凯洱生物破产资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2579197483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579197483?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:00","pubTimestamp":1761814838,"startTime":"0","endTime":"0","summary":"哈三联(002900.SZ)公告称,公司于2025年10月30日通过淘宝网阿里拍卖破产强清平台以起拍价2643万元竞得威凯洱生物破产资产,包括存货、房屋建筑物、构筑物、设备、土地使用权等。该交易为关联交易,资金来源为自有资金,不会对公司财务状况和经营成果产生重大不利影响。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000030996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2578978677","title":"哈三联第三季度净利亏损过亿元 同比降超900%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578978677","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578978677?lang=zh_cn&edition=full","pubTime":"2025-10-28 03:14","pubTimestamp":1761592440,"startTime":"0","endTime":"0","summary":" 近日,哈尔滨三联药业股份有限公司发布的2025年第三季度报告显示,公司业绩出现下滑,其中净利亏损过亿元,同比降超900%。 数据显示,哈三联2025年前三季度营业收入为5.81亿元,同比下降30.75%;归属于上市公司股东的净利润亏损约2.09亿元,同比下降614.61%。归属于上市公司股东的扣除非经常性损益的净利润为亏损1.21亿元,同比降幅高达1113.19%。 随后,在2025年上半年,哈三联亏损进一步加大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-28/doc-infvkqec1666717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2578683168","title":"哈三联(002900)2025年三季报简析:净利润同比下降614.61%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2578683168","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578683168?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:13","pubTimestamp":1761430418,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期哈三联发布2025年三季报。截至本报告期末,公司营业总收入5.81亿元,同比下降30.75%,归母净利润-2.09亿元,同比下降614.61%。按单季度数据看,第三季度营业总收入1.68亿元,同比下降46.83%,第三季度归母净利润-1.16亿元,同比下降913.69%。本报告期哈三联三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达57.21%。去年的净利率为4.85%,算上全部成本后,公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600002079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900"],"gpt_icon":0},{"id":"2578660574","title":"哈三联(002900)10月20日股东户数3.83万户,较上期增加1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578660574","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578660574?lang=zh_cn&edition=full","pubTime":"2025-10-25 17:23","pubTimestamp":1761384238,"startTime":"0","endTime":"0","summary":"证券之星消息,近日哈三联披露,截至2025年10月20日公司股东户数为3.83万户,较9月30日增加737.0户,增幅为1.96%。在化学制药行业个股中,哈三联股东户数高于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.26万户。从股价来看,2025年9月30日至2025年10月20日,哈三联区间涨幅为2.82%,在此期间股东户数增加737.0户,增幅为1.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500014839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0},{"id":"2577512348","title":"哈三联最新公告:前三季度亏损2.09亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577512348","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577512348?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:48","pubTimestamp":1761313730,"startTime":"0","endTime":"0","summary":"哈三联(002900.SZ)公告称,公司第三季度营业收入1.68亿元,同比下降46.83%;净利润-1.16亿元。2025年前三季度营业收入5.81亿元,同比下降30.75%;净利润-2.09亿元。受国家药品采购相关政策影响,以及公司部分非集采制剂产品市场竞争加剧,公司部分产品销售价格下降。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400041749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2577353777","title":"10月22日哈三联(002900)涨停分析:化妆品业务增长、新业务拓展驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2577353777","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577353777?lang=zh_cn&edition=full","pubTime":"2025-10-22 15:32","pubTimestamp":1761118328,"startTime":"0","endTime":"0","summary":"证券之星消息,哈三联10月22日涨停收盘,收盘价14.61元。该股于9点39分涨停,未打开涨停,截止收盘封单资金为8890.55万元,占其流通市值3.48%。10月22日的资金流向数据方面,主力资金净流入1.17亿元,占总成交额53.92%,游资资金净流出5936.02万元,占总成交额27.44%,散户资金净流出5728.53万元,占总成交额26.48%。近5日资金流向一览见下表:该股为医美,新冠病毒防治,医药概念热股,当日医美概念上涨0.77%,新冠病毒防治概念上涨0.43%,医药概念上涨0.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200019055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002900","BK0239"],"gpt_icon":0},{"id":"2577038745","title":"异动快报:哈三联(002900)10月22日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2577038745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577038745?lang=zh_cn&edition=full","pubTime":"2025-10-22 09:40","pubTimestamp":1761097255,"startTime":"0","endTime":"0","summary":"证券之星10月22日盘中消息,9点39分哈三联触及涨停板。目前价格14.61,上涨10.02%。其所属行业化学制药目前上涨。领涨股为广济药业。该股为医美,医药,创新药概念热股,当日医美概念上涨0.95%,医药概念上涨0.94%,创新药概念上涨0.83%。10月21日的资金流向数据方面,主力资金净流出295.59万元,占总成交额5.02%,游资资金净流入104.63万元,占总成交额1.78%,散户资金净流入190.96万元,占总成交额3.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200009101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002900"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765155146750,"stockEarnings":[{"period":"1week","weight":-0.0176},{"period":"1month","weight":-0.0141},{"period":"3month","weight":-0.0265},{"period":"6month","weight":-0.0542},{"period":"1year","weight":0.283},{"period":"ytd","weight":0.4367}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"哈尔滨三联药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39668人(较上一季度增加3.21%)","perCapita":"4410股","listingDate":"2017-09-22","address":"黑龙江省哈尔滨市呼兰区利民开发区北京路","registeredCapital":"31635万元","survey":" 哈尔滨三联药业股份有限公司的主营业务是化学药品制剂及特色原料药的研发、生产和销售。公司的主要产品是神经系统药物、心血管系统、肌肉-骨骼系统药物、全身用抗感染药、血液和造血器官药、抗肿瘤药及免疫调节剂、消化道和代谢方面的药物、抗生素系列、驱虫药系列、解热镇痛类药物及营养补充剂、大健康板块。公司先后被认定为高新技术企业、国家企业技术中心、国家博士后科研工作站,连续六年入选“中国化药企业TOP100榜单”,公司综合能力与研发实力不断增强。","listedPrice":18.07},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"哈三联(002900)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供哈三联(002900)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"哈三联,002900,哈三联股票,哈三联股票老虎,哈三联股票老虎国际,哈三联行情,哈三联股票行情,哈三联股价,哈三联股市,哈三联股票价格,哈三联股票交易,哈三联股票购买,哈三联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"哈三联(002900)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供哈三联(002900)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}